41,000 truck drivers tested positive for marijuana in 2022
Marking a 32% increase compared to 2021m a whopping 41,000 truck drivers tested positive for the substance, according to the Federal Motor Carrier Safety Administration’s Drug & Alcohol Clearinghouse.
Decriminalization of marijuana may lead to changes in drug testing policies for truck drivers, as employers may be less likely to test for marijuana use, or may revise their policies to allow for the use of marijuana in certain circumstances. Decriminalization may also affect hiring practices in the trucking industry, as employers may be more willing to hire individuals who have used marijuana in the past, or who use marijuana for medical purposes. The decriminalization of marijuana may raise concerns about the impact of marijuana use on workplace safety, particularly for truck drivers who operate heavy vehicles on public roads. This may also have an impact on insurance rates for trucking companies, as insurance providers may adjust their pricing to reflect the potential risks associated with marijuana use.
Despite changes in state law, marijuana remains illegal under federal law, which creates challenges for the trucking industry, as truck drivers are subject to federal regulations, regardless of state laws.
The Supreme Court is set to hear a significant case involving Douglas J. Horn, a commercial truck driver who lost his job after testing positive for drugs.
Drug shortages in the U.S. have hit a record high this year, with the American Society of Health-System Pharmacists (ASHP) reporting 323 active shortages.
The U.S. is currently experiencing shortages of new weight loss drugs, including Zepbound and Wegovy, primarily due to soaring demand.
It turns out that around 1 in 10 people in the US who rely on Adderall and similar meds for ADHD are hitting a wall due to a medication shortage.
Recently, there was a major drug bust in the Caribbean Sea near Colombia.
In the world of drug and vaccine development, long-tailed macaques are like gold, fetching prices of $50,000 or more in the US. But the journey from the Cambodian forests to the labs is anything but ethical or smooth.
U.S. Customs and Border Protection officers at Eagle Pass Port of Entry had a successful day intercepting methamphetamine shipments, seizing three loads valued at over $847,000 in total.
The Food and Drug Administration has given Florida the green light to import medications from Canada - a move aimed at lowering drug prices in the United States.
Ohio has become the 24th state to legalize recreational marijuana, following voter approval of Issue 2 in the November election.
U.S. Customs and Border Protection officers seized 354 pounds of methamphetamine hidden in the bed of a pickup truck crossing the border from Mexico into the United States at the Paso Del Norte international crossing.
Rite Aid, a debt-laden U.S. pharmacy chain, has filed for bankruptcy protection and plans to close underperforming stores, sell its pharmacy benefit subsidiary Elixir, and address lawsuits related to the sale of addictive opioid medications.
Novo Nordisk has raised its full-year sales and operating profit outlook due to high demand for its weight loss drug Wegovy and diabetes treatment Ozempic.
The Naval Special Warfare Center conducted over 2,500 screening tests between February 2022 and March 2023, identifying 74 SEAL or Special Warfare Combat Crewmen with elevated testosterone levels, leading to three candidates testing positive for performance-enhancing drugs.
Congress is taking action to address the critical shortage of pharmaceutical drugs in the U.S., which has been exacerbated by the COVID-19 pandemic.
A bipartisan group of senators has introduced a bill aimed at strengthening the pharmaceutical supply chain by increasing drug manufacturing in the U.S. and allied countries.
A severe shortage of penicillin, the recommended treatment for syphilis, has U.S. health officials considering a public health emergency declaration.
This article discusses the unique complexities and challenges faced by pharmaceutical supply chains.
The marijuana supply chain faces unique challenges due to legal restrictions and state-specific regulations.
The ongoing drug shortage crisis in the United States, particularly in the field of cancer drugs, highlights the failures of the pharmaceutical supply chain and the U.S. Food and Drug Administration (FDA).
The marijuana supply chain presents unique challenges due to legal restrictions and the delicate balance between supply and demand.
The overall positivity rate for drug tests in the U.S. workforce has reached a 20-year high due to the legalization of recreational marijuana in some states, according to Quest Diagnostics.
A congressional report reveals that the United States is grappling with critical medication shortages, prompting bipartisan senators to investigate the potential national security implications.
Michigan Senator Gary Peters and Iowa Senator Joni Ernst are introducing legislation to tackle medication shortages and assess the impact on national security.
The Biden administration has announced a new initiative to combat the flow of illicit drugs, with a particular focus on fentanyl
The logistics of drug trafficking involve the movement of illegal drugs, such as cocaine, heroin, and methamphetamine, from production sites to distribution centers and ultimately to the end user.
Marijuana use can impair judgment, coordination, and reaction time, which can increase the risk of accidents and injuries.
Marking a 32% increase compared to 2021m a whopping 41,000 truck drivers tested positive for the substance, according to the Federal Motor Carrier Safety Administration’s Drug & Alcohol Clearinghouse.
RxPass is the company’s latest launch that will provide a subscription service to customers who already pay for Prime memberships.
On a federal level, cannabis remains an illegal substance in the United States.
The Biden administration is gearing up to make a historic shift by planning to reclassify cannabis under federal law.